Suzhou Wangshan Wangshui Bio-Pharmaceutical Co., Ltd., established on 2013-01-21, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Health food production;Health food sales;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;R&D and application of cell technology;Biochemical product technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Northeast Pharmaceutical Group Co., Ltd ("Northeast Pharm" for short), established in 1946, is a large-scale comprehensive pharmaceutical enterprise in China. Northeast Pharm is dedicated to the establishment of the whole industrial chain from R&D, production, medical commerce to medical engineering service. With the development for more than half of a century, Northeast Pharm has 352 national registration approval number, 12 series, over 400 raw materials and finished products. Manufacturing capacity is more than 13 billion units annually. Sales network covers more than 100 countries and areas in the world. Creation is the source of vitality. They challenge the unknown and impossibility. Northeast Pharm has established a series of high-end science and technology platforms encompassing national technology center, medical industry research institute, designing institute, new drug incubation center, quality inspection center, post-doctoral scientific research station. Northeast Pharm has top-end experts and management personnel who enjoy great popularity in several fields, such as gynecology, andrology, intestine, cardiovascular, anti-AIDS, Narcotic psychotropic and anti-infection medicines. Northeast Pharm insists on developing high quality chemical medicine and biological medicine using the best quality raw materials and the most advanced technology. All the products meet the latest standards of Chinese Pharmacopoeia, European Pharmacopoeia and United States Pharmacopeia. Following the principle of "Everything for your health", Northeast Pharm is dedicating to continuous technology innovation and providing high quality products and professional services to their customers and partners in the pharmaceutical and nutritional business.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

CSSC (Handan) Perry Special Gas Co., Ltd., established on 2016-12-21, Business scope includes licensed projects:Hazardous Chemical Production;Hazardous Chemicals Management;Portable Pressure Vessel/Cylinder filling.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Research and development of special electronic materials;Electronic special material manufacturing;Sales of electronic special materials;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Rare rare earth metal smelting;New material technology research and development;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Suzhou Qiangyao Biotechnology Co., Ltd., established on 2012-08-02, Business scope includes biological products(polypeptide,protein,Antibody,small molecule compound)technology development,Technical Services,technology transfer;equipment,Biological reagents and consumables,Chemical raw materials and products(Does not contain dangerous goods)Sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(The above involves licensing,Operate only after obtaining a license)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhejiang Pai Pei Biological Co., Ltd., established on 2015-07-06, Business scope includes production,Sales,research and development:Polypeptide series products raw materials(Oxytocin acetate,Glatiramer acetate,Terlipressin,Thymopentin,Leuprolide Acetate,Liraglutide,Bivalirudin,carbetocin acetate,Exenatide Acetate)and pharmaceutical intermediates,Provide technical services and transfer of results;Production,Sales,research and development:Polypeptide cosmetic raw materials and cosmetics;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Linglan Biomedical Technology Co., Ltd., established on 2017-07-18, Business scope includes general business items:new drug,Drug intermediate,Research and development of pharmaceutical preparations and health products;Development of biomarkers and disease diagnostic kits;transfer of own technology,And provide relevant technical advice,Technical Services;provide experimental design,data analysis,Compound Research and Preclinical Research,quality inspection,Biotechnology Experiment Service.,The licensing program is:new drug,Drug intermediate,Highly specific small molecules for signaling pathways,Chinese herbal extracts and their refined products,Production and sales of chemical reference substances;Wholesale of health products,retail.

Arigene is a developer, manufacturer and marketer of Ubiquitous Healthcare Systems (U-Healthcare) and related medical equipment in Korea. With its planned acquisition of Trimeris, Inc., Arigene is expanding its business to the broader biotechnology industry.

Anhui Baishansheng Pharmaceutical Co., Ltd., established on 2016-05-18, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Chemical product production(No licensed chemical products);Sales of daily chemical products;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of medical packaging materials(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Xi'an Tiangong Biomedical Research Institute Co., Ltd., established on 2018-03-22, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Health Consulting Services(Does not include medical services);Chemical product production(No licensed chemical products);Manufacturing of daily chemical products;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Instrument sales;software sales;Cosmetics Wholesale;Cosmetics Retail.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangsu Yangtze River Pharmaceutical Group Co., Ltd. manufactures and distributes pharmaceutical products. It is a large cross-regional pharmaceutical group that features industry-university-institute cooperation and integrates scientific research, industrial production and sale. The company was founded in 1971 and is headquartered in Taizhou, China.

NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom.

NATA specializes in the research and development, production, and sales of high-purity electronic materials. Relying on the advantages of technology accumulation for more than 30 years, the company has successively conquered the industrialization of the whole series of MO source products of the national 863 plan, the R&D and industrialization of the national "02-special" high-purity electronic gas (arsine, phosphine), and the precursors of ALD/CVD. It has filled a number of domestic blanks, including many projects that have plagued our country for decades, such as the industrialization of the body. In 2017, NTU Optoelectronics undertook the R&D and industrialization project of 193nm photoresist material, one of the key core materials for integrated circuit chip manufacturing.

Shanghai Ambo Biotechnology Co., Ltd., established on 2007-05-28, Business scope includes licensed projects:pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Sales of company-produced products;Technology development and technology transfer services for peptide products,Technical consulting and drug production management consulting services in the field of peptides.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.